Achievement and Usefulness of Intermediate Treatment Targets for Still Disease Proposed by the European Alliance of Associations for Rheumatology and the Paediatric Rheumatology European Society
The EULAR/PReS intermediate treatment targets for Still disease are useful in the clinical management of AOSD.
Authors
- H. Tamai (ORCID: https://orcid.org/0000-0001-8784-2224)
- Yuko Kaneko (ORCID: https://orcid.org/0000-0003-2646-5765)
- Shinichiro ITO (ORCID: https://orcid.org/0000-0001-7275-140X)
- Yasushi Kondo (ORCID: https://orcid.org/0000-0002-1566-2088)
- Satoshi Takanashi (ORCID: https://orcid.org/0000-0002-3607-2140)
Institutions
- Keio University (JP)
- Public Health Dayton & Montgomery County (US)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.3899/jrheum.2024-1126
- Citations
- 2
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 3.54